The UK’s MHRA has approved the first GLP-1 receptor agonist tablet for weight loss, offering a more convenient alternative to weekly injections. Semaglutide, branded as Wegovy, is now available in pill form for adults with obesity or those who are overweight with weight-related health conditions. Patients can transition directly from the weekly injection to the 25 mg daily tablet.
According to the CGPSC, the candidates had appeared for document verification, physical tests and the…
India's investor community is witnessing remarkable transformation, with a younger demographic leading the growth. The…
Legendary actor Mithun Chakraborty is currently in the hospital in Kolkata following a minor surgical…
In 2012, a wildfire swept across Africa's Rwenzori Mountains, marking the first such event in…
Want recurring revenue instead of one-off course sales? Here's how to build a course membership…